In Vitro Study of the Combination of Doxorubicin, Curcuma xanthorrhiza, Brucea javanica, and Ficus septica as a Potential Novel Therapy for Metastatic Breast Cancer by Sutejo, Ika Rahmawati et al.
 
VOL 30 (1) 2019: 15 – 24 | RESEARCH ARTICLE 
  15 
 Indonesian Journal of Pharmacy 
Indonesian J Pharm 30(1), 2019, 15-24 | DOI: 10.14499/indonesianjpharm30iss1pp15 indonesianjpharm.farmasi.ugm.ac.id 
Copyright © 2019 THE AUTHOR(S). This article is distributed under a Creative Commons Attribution-ShareAlike 4.0 
International (CC BY-SA 4.0) 
 
In Vitro Study of the Combination of Doxorubicin, Curcuma 
xanthorrhiza, Brucea javanica, and Ficus septica as a Potential Novel 
Therapy for Metastatic Breast Cancer  
 
Ika Rahmawati Sutejo1,3, Herwandhani Putri3, Sri Handayani3,4, Riris Istighfari Jenie2,3 and                 
Edy Meiyanto2,3* 
 
1. Department of Biochemistry, Faculty of Medicine, University of Jember, Jalan Kalimantan 37 Jember 
68121, Indonesia  
2. Department of Pharmaceutical Chemistry Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara 
Yogyakarta 55281, Indonesia 
3. Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara 
Yogyakarta 55281, Indonesia 
4.
    Research Unit for Natural Product Technology, Indonesian Institute of Sciences (LIPI), Jalan Jogja - 
Wonosari, km 31.5, Kec. Playen, 174 WNO, Gading II, Gading, Playen, Kabupaten Gunung Kidul, Daerah 
Istimewa Yogyakarta 55861, Indonesia 
Info Article ABSTRACT 
Submitted: 30-10-2018 
Revised: 17-1-2019 
Accepted: 13-3-2019 
 
*Corresponding author 
Edy Meiyanto 
 
Email: 
meiyan_e@ugm.ac.id  
Less optimized therapeutic effects constrain the use of doxorubicin as 
the main agent of chemotherapy for metastatic breast cancer, resistance and 
side effects. Therefore we need a combination of more than one 
chemopreventive agent which has different molecular targets to solve that 
problem. The aims of this study is to prove the inhibitory effect of ethanolic 
extract of rhizome of Curcuma xanthorrhiza (ECx), fruit of Brucea javanica 
(EBj), leave of Ficus septica (EFs) and doxorubicin (Dox) alone and its 
combination on migration and invasion of a highly metastatic 4T1 breast 
cancer cell line. Cytotoxic activity of single and combination treatment was 
evaluated by MTT assay, followed by an experiment of apoptosis induction 
by using flow cytometry. The inhibitory effect on migration was observed by 
the scratch wound-healing assay. Furthermore, the observation of the 
activity of matrix metalloproteinase-9 (MMP-9) was analyzed by gelatin 
zymography. The results showed that ECx, EBj, EFs, and Dox has cytotoxic 
activity on 4T1 cells with the value of IC50 respectively 49.7±1.53g/mL, 
59.9±1.79g/mL, 15.2±2.12g/mL and 1.2±0.23M. Furthermore, the 
combination of ECx-EBj-Dox and ECx-EBj-EFs revealed a synergistic effect 
on 4T1 cells and decrease cell viability through the induction of apoptosis 
and necrosis. Based on wound healing assay, 24h incubation of this 
combination inhibited 4T1 cells migration compared to single treatment. 
Gelatin zymography analysis showed that this combination also inhibited 
the activity of MMP-9 greater than a single use. Curcuma xanthorrhiza, 
Brucea javanica, and Ficus septica may have potential to be developed as a 
combination with or without doxorubicin for metastatic breast cancer 
treatment. 
Keywords: C xanthorrhiza,  B javanica, F septica,  antimetastasis, 4T1 cells. 
 
INTRODUCTION 
Breast cancer is the first leading cause of 
cancer deaths in women. Doxorubicin is an 
important modality for the treatment of breast 
cancer metastasis in addition to surgery (Bapsy 
and Sahoo, 2006). Long term use of doxorubicin 
causes several side effects, resistance and toxicity 
to normal tissues (Smith et al., 2010). Therefore, 
combining doxorubicin with the chemopreventive 
agent is needed to increase the activity of 
doxorubicin, to overcome the drug resistance and 
to reduce its side effect (Sarkar and Li, 2006). 
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The chemopreventive agent used in this 
research is a combination of Brucea javanica (EBj), 
Ficus septica (EFs) and Curcuma xanthorrhiza 
(ECx). Many clinical studies have suggested that 
Brucea javanica can be used alone as a 
conventional treatment for various cancers. 
However, the present study shows that Brucea 
javanica has synergistic effects when combined 
with certain anticancer drugs or radiotherapy  
(Nie et al., 2012). The leaves of Ficus septica            
have been used to treat various cancers. The 
ethanolic extract of Ficus septica showed a 
cytotoxic effect on breast cancer T47D cell lines 
with an IC50 value of 13µg/mL. The extract at 
4.88µg/mL also showed an optimum synergistic 
effect in combination with doxorubicin (3.75nM) 
(Pratama et al., 2010). Besides, the extract  
induced apoptosis and downregulated the 
expression of Bcl-2 protein in breast cancer             
cells MCF-7  (Sekti et al., 2010). The principal 
components of Curcuma xanthorrhiza are 
curcumin and xanthorrhizol. Curcumin suppresses 
many key elements in cellular signal transduction 
pathways pertinent to growth, differentiation, and 
malignant transformation (Kunumakkara et al., 
2008). Choi et al. (2005) observed that injection  
of 0.2-1.0mg/kg BW xanthorrhizol had an 
antimetastatic effect in a mouse lung metastasis 
model. 
There have been several reports about the 
combination of doxorubicin with one kind of 
chemopreventive agent, and its synergistic has 
been proved (Lewandowska et al., 2014), but  
study using a combination of more than one kind 
of chemopreventive agents with doxorubicin has 
not been done, mainly to prove its effectiveness as 
an antimetastasis agent in advanced breast cancer. 
This research combined ECx, and EBj with Dox to 
increase effectivity, to overcome drug resistance, 
and to reduce its side effect while the combination 
of three chemopreventive agents (ECx, EFs and 
EBj) without chemotherapy Dox is assumed to get 
nontoxic nature of EFs and to eliminate the side 
effect of Dox. 
 
MATERIAL AND METHODS 
The rhizome of Curcuma xanthorrhiza, the 
fruit of Brucea javanica and the leave of Ficus 
septica was macerated with 70% ethanol. The 
procedure was done at Medicinal Plant and 
Traditional Medicine, Research and Development 
Centre (B2P2TO-OT) Tawangmangu, Indonesia. 
Doxorubicin was obtained from  Sigma. A  DMSO 
(Merck) solution was used to dilute ethanolic 
extract of ECx, EFs and EBj.  The final DMSO 
concentration was set at less than 1%. 
 
Cells culture 
4T1 murine mammary carcinoma cells were 
acquired from Prof. Masashi Kawaichi (Nara 
Institute of Science and Technology, Japan) and 
maintained in Dulbecco's Modified Eagle's 
Medium (DMEM) high glucose containing Fetal 
Bovine Serum (FBS) 10% (v/v) (Sigma), penicillin-
streptomycin 1% (v/v) (Gibco) and Fungizone 
0.5% v/v (Gibco) in a humidified atmosphere of 
5% CO2 in air 37°C.  
 
Cytotoxicity assay 
Various concentrations of samples (ECx, 
EBj, EFs, Dox, and its combination), DMEM culture 
medium (Gibco) with 10% FBS, 1% penicillin-
streptomycin and fungizone were used to conduct 
the cytotoxic colorimetric MTT assay on 4T1 
breast cancer cells. It was used to determine the 
IC50 value. Afterwards, a cytotoxicity assay was 
also conducted to determine the effect of the 
combination of various sample concentrations 
treatment (Mosmann, 1983). 
 
Flow cytometric apoptosis assay 
Cells were added with Annexin-V-FLUOS 
Staining Kit (Roche) consisting of 200µL of binding 
buffer, 2µL of Annexin V, 2µL propidium iodide 
(PI) and incubated for 10min in the dark room 
according to manufacturer's instruction, then 
transferred into a flow cytometry tube and 
analyzed by flow cytometer (BD FACS Calibur, BD 
Bioscience) (Engeland et al., 1998). 
 
Scratch wound healing assay 
The 4T1 cells (7.5x104) were cultured in 
24-well plate and incubated for 24h. After 
starvation, cells were scratched by using sterile 
yellow tip then treated with various concentrations 
of samples. The cells were documented at 0, 18, 
and 24h (Liang et al., 2007).  The results were 
analyzed by using ImageJ software and converted 
to percentage closure parameter. 
 
Gelatin zymography 
The SDS-PAGE 8% supplemented with 0.1% 
gelatin was used to determine the activity of MMP-
9 in the culture medium. After electro-phoresis 
running, gels were washed and incubated at room 
temperature. The reaction buffer was added and 
incubated   for  24h  at  37°C.  Gels  were stained by  
using Coomassie Brilliant Blue R-250 (Sigma) and 
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destained until clear bands with dark blue 
background appeared (Kupai, 2011). The results 
were documented and analyzed by using Image J 
software. 
 
Statistical analysis 
Oneway ANOVA followed by the least 
significant difference (LSD) were used to assess 
the statistical significance. A statistically significant 
difference was considered to be present at p<0.05. 
The results of scratch wound healing assay and 
gelatine zymography were documented and 
analyzed using Image J software before ANOVA. 
 
Combination cytotoxicity assay and synergicity 
The effect of combination treatment on 4T1 
cells was evaluated by calculating the Combination 
Index (CI) value using the formula. Interpretation 
of the data was based on the classification 
(Reynolds and Maurer, 2005). 
 
RESULTS AND DISCUSSION 
Effects of ECx, EBj, EFs, Dox alone and its 
combination on cell viability of 4T1  
A single treatment of ECx, EBj, EFs, or Dox 
showed cytotoxic effect on 4Tl breast cancer cells 
with IC50 value respectively 49.7±1.53g/mL, 
59.9±1.79g/mL, 15.2±2.12g/mL and 1.2±0.23M 
(Figure 1). The reduction of cell viability of 
combination of ECx-EBj-EFs and ECx-EBj-Dox is 
greater than the single treatment. The 
combination of ECx-EBj-Dox using concentrations 
of ½ IC50 showed synergistic effects with a CI 
value of 0.63 and reduced cell viability up to 65% 
(Sutejo, 2015). The combination of ECx-EBj-EFs 
using concentrations of ½ IC50 showed synergistic 
effects with a CI value of 0.83 and reduced cell 
viability up to 63% (Figure 2).   
 
The combination of ECx-EBj-EFs and ECx-EBj-
Dox increase apoptosis and necrosis on 4T1 
cells 
The observation of apoptosis was done by 
using concentration ⅓IC50 of each agent. All single 
treatments and combination induced apoptosis on 
4T1. The percentage of living cells in control was 
92.18%, while the percentage of apoptotic cells is 
6.34% and necrotic cells were 2.17%. After a 
single treatment ECx, EBj, EFs, and Dox, the 
percentages of cells undergoing apoptosis were 
respectively 12.08%, 6.22%, 10.47% and 13.41%. 
The treatment with ECx-EBj-EFs and ECx-EBj-Dox 
for 24h incubation increased the apoptotic cells by 
14.46% and 11.99% (Figure 3).  
The combination of ECx-EBj-EFs and ECx-EBj-
Dox inhibit migration of 4T1 cells 
The observation of cell migration activity 
was done by using concentration ¼ IC50 of each 
agent. The effect on cell migration was observed at 
time point 0, 18, and 24h. The single treatment of 
ECx, EBj, EFs, Dox and its combination decrease 
cell migration of 4T1. The ability of the most 
robust inhibition to the lowest showed by the 
combination of ECx-EBj-EFs, ECx-EBj-Dox, and 
then ECx, EFs, followed by EBj, and the least one 
was doxorubicin (Figure 4).  
 
The combination of ECx-EBj-EFs and ECx-
EBj-Dox inhibit activity of MMP-9 on 4T1 cells 
The treatment was done by using 
concentration ¼ IC50 of each agent. The single 
treatment of ECx, EFs, and EBj is more potential to 
inhibit the activity of MMP-9 than doxorubicin. 
The combination of ECx-EBj-EFs and ECx-EBj-Dox 
resulted in much greater inhibition of MMP-9 
activity than a single treatment (Figure 5). 
 
Discussion 
The single treatment of ECx, EBj, EFs, and 
Dox was proven to have a cytotoxic effect on 4T1 
cells (Figure 1), and its combination showed a 
synergism to reduce cell viability greater than a 
single treatment (Figure 2). It was supported by 
the previous study statements that each Curcuma 
xanthorrhiza, Brucea javanica, and Ficus septica 
increased the effects of chemotherapy 
(Kunnumakkara et al., 2008). Combination of ECx-
EBj-EFs was as potent as ECx-EBj-Dox to induce 
4T1 cells death (Figure 3). Mechanism of cell 
growth inhibition both two combinations was due 
to apoptosis and necrosis pathways. The 
molecular mechanisms underlined the apoptosis 
after treatment of ECx, EBj and EFs in 4T1 cells 
was through p53-independent pathways, due to 
4T1 breast cancer cells line characteristic which is 
lack of protein p53 expression (Tao et al.,         
2008). Whereas doxorubicin induces necrosis 
through increased TNFα and ROS (Sugimoto et al., 
2002). 
The rhizomes of Curcuma xanthorrhiza 
contains volatile oil, saponin,  flavonoid,                       
and tannin. Chemistry analysis showed that                   
the main substances of Curcuma xanthorrhiza             
are curcumin, desmethoxycurcumin and 
xanthorrhizol (Choi et al., 2005). Most of the 
studies on Ficus septica leaves reported on the 
phenanthroindolizidine alkaloid which has a 
cytotoxic effect on cancer cells (Sekti et al., 2010). 
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Figure 1. Cytotoxic effect of single treatment of ECx, EBj, EFs, and Dox on 4T1 Cells. 5x103 cells/well were 
seeded in 96 well plate and incubated for 24h, then treated with ECx, EBj, EFs and Dox. Cell viability was 
determined by using MTT assay as described in the method. Morphology cells after a single treatment of 
ECx, EBj, EFs (A) or Dox (B) for 24h. Arrows indicate cell morphological changes. Cell viability profile after 
a single treatment of ECx, EBj, EFs (C) or Dox (D) for 24h. Profile of cell viability were means ± SD from 3 
independent experiments. 
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Several natural components from Brucea javanica 
fruit include the tetracyclic triterpene quassinoids, 
anthraquinone, olein, oleic acid, linoleic  acid, 
pregnane glucosides, and  sesquiterpenes. In 
particular, tetracyclic triterpene quassinoids 
(brucein A and bruceantin) are the main active 
ingredients of Brucea javanica with remarkable 
antitumor activity (Chen et al., 2013).  
The treatment of ECx, EBj, EFs, and                   
Dox alone or in combination inhibited the 
migration of 4T1 breast cancer cells (Figure 4). 
The interesting finding was that Dox as the                
main chemotherapy in advanced   cancer   has   the   
lowest  antimigration   activity   compared             to  ECx,  
EBj and EFs (Figure 4). Bandyopadhyay et al. 
(2010) and Krstic and Santibanez (2014) proved 
that doxorubicin increases migration and           
invasion of 4T1 and MDAMB-231cells through 
induction of TGFβ. Those findings in line with our 
result that the combination of ECx-EBj-EFs 
inhibited cells migration greater than ECx-                    
EBj-Dox. Metastasis inhibition of doxorubicin 
which was seen in this study was due to cell death 
caused by doxorubicin treatment. Although the 
mechanism is not clear, single doxorubicin              
proved to inhibit the M5076 ovarian cancer                
cell metastasis in vivo (Sugiyama and Sadzuka, 
1999).  
 
 1/6 IC50 1/4 IC50 1/3 IC50 ½ IC50 
ECx (µg/mL) 8.3 +   + 12.5 +   + 16.7 +   + 25 +   + 
EBj (µg/mL) 10  +  + 15  +  + 20  +  + 30  +  + 
Dox (µM) 0.2   + + 0.3   + + 0.4   + + 0.6   + + 
 
 
 1/6 IC50 1/4 IC50 1/3 IC50 ½ IC50 
ECx (µg/mL) 8.3 +   + 12.5 +   + 16.7 +   + 25 +   + 
EBj (µg/mL) 10  +  + 15  +  + 20  +  + 30  +  + 
EFs (µg/mL) 2.5   + + 3.75   + + 5   + + 7.5   + + 
 
Figure 2. Combination effect of ECx, EBj, EFs, and Dox on the viability of 4T1 cells. 5x103 cells per well 
were incubated for 24h and exposed with various concentrations of (A) ECx, EBj, or Dox alone and its 
combination, (B) ECx, EBj, or EFs alone and its combination, then subjected for MTT assay.  A 
combinational treatment yielded less cell viability compared to a single treatment (p 0.05). Cytotoxicity 
was represented as a percentage of  4T1 cells viability as the mean±SE of three values. 
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Several reports related to the anti-
metastasis potency of the active compounds 
contained in the extracts we used are as follows. 
Curcumin as the main active ingredient of ECx, 
inhibit the migration of breast cancer cells 
MDAMB-231 by suppressing the FAK pathway and 
lowering the expression of PI3K and were 
subsequently able to decrease the expression of 
VEGF (Lin et al., 2009). Curcumin also inhibits the 
expression of MMP-9 causing a decrease of MMP-9 
activity, inhibits β-catenin and reduce the loss of 
E-cadherin, which is related to the ability of 
invasion and metastasis of cancer cells 
(Thangapazham et al., 2006). Alkaloids phenanthro-
indolizidine from Ficus septica inhibits expression 
of    COX-2   proteins    (Mandhare    et    al.,   2015).  
 
 
 
Figure 3. Apoptosis effects of ECx, EBj, EFs, and Dox single and its combination on 4T1. Cells were 
harvested after treatment of 16.7 µg/mL of  ECx, 20 µg/mL of EBj,  5 µg/mL EFs and 0.4 μM Dox for 24h 
single or in combination, then stained using Annexin V-FITC/PI and were analyzed by using flow 
cytometry. (A) The distribution profiles of living cells (R1), early apoptosis (R2), late apoptosis (R3), and 
necrosis (R4), (B) quantification of cells undergoing early apoptosis, late apoptosis and necrosis. 
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Brucein A and bruceantin are known to inhibit the 
invasion and migration of tumour cells targeting at 
MRP-1/CD9 and integrinα-5 (Nan et al., 2015). 
Brucein A from Brucea javanica lowered VEGF 
expression so that no signal is transmitted through 
the VEGF receptor (Xinjie and Linyi, 2013). 
Moreover, Brucea javanica and Ficus septica also 
suppress the activation of NF-кB and inhibits 
expression of COX-2 proteins that promote 
invasion (Kim et al., 2010; Mandhare et al., 2015). 
The mechanisms above explain our findings that 
the combination of ECx-EBj-EFs and ECx-EBj-Dox 
inhibited cells migration greater  than  the single   
treatment   (Figure 4B).  
 
 
 
 
Figure 4. Effects of ECx, EBj, EFs, and Dox alone and its combination on 4T1 cell migration. (A) The 
morphology of the cells after the scratch and treated with 12.5 µg/mL ECx; 15 µg/mL EBj, 3.75 μg/mL  
EFs, or 0.3 µM Dox single and its combination. The observation was made after 0, 18, 24, and 42h of 
treatment under an inverted microscope with 100x magnification. (B) The percentage of 4T1 closure 
after 18h and 24h of treatment. The value was a means of % closure ± SD from 3 independent 
experiments. The area of the scratch was analyzed using ImageJ software then % closure was calculated 
following the procedure of the analysis. The asterisk (*) indicates differences (p<0.95; n=3) 
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The fact that Dox has not only induced cell 
migration but also cell invasion also explains our 
data that the combination of ECx-EBj-EFs inhibited 
MMP-9 activity greater than ECx-EBj-Dox (Figure 
5B).  
 
CONCLUSION 
The results of this study conclude that both 
two combinations of ECx-EBj-Dox and ECx-EBj-EFs 
have a cytotoxic effect via apoptosis and necrosis 
pathways. The combination of ECx-EBj-EFs has 
antimigration activity and inhibition of cancer cell 
invasion greater than ECx-EBj-Dox. Both two 
combinations have a potency to be developed as a 
co-chemotherapy agent in breast cancer 
metastasis. Nevertheless, further researches are 
still needed in order to apply such combination 
therapy for cancer patients. 
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